Source: Annual Congress 2002 - COPD - general -3
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
B. Lara, M. Miravitlles, S. Vilà, C. de la Roza, I. Garca-Talavera, P. P. España, J. C. Barros-Tizón, A. Bustamante, R. Vidal (Barcelona, Spain). Alpha-1-antitrypsin deficiency patients (AATD): two-year follow-up. Eur Respir J 2002; 20: Suppl. 38, 1672

Member's Comments

No comment yet.

Related content which might interest you: What makes Alpha1-antitrypsin deficiency patients exacerbate: a 5-year cohort Source: Virtual Congress 2021 – Biomarkers to phenotype COPD: prediction of exacerbations Year: 2021 Mortality in individuals with severe alpha-1-antitrypsin deficiency (PiZZ) Source: Eur Respir J 2006; 28: Suppl. 50, 144s Year: 2006 Erythrocyte abnormalities in alpha-1-antitrypsin deficiency (AATD) patients Source: Annual Congress 2009 - COPD: exacerbation and clinical problems Year: 2009 Prevalence of alpha-1-antitrypsin deficiency (A1AD) in patients with COPD. Source: Virtual Congress 2021 – COPD burden, epidemiology and management Year: 2021 Clinical, functional, radiologic and quality of life characteristics in PI*SZ Alpha 1-Antitrypsin Deficiency (AATD) compared to PI*ZZ, PI*MZ and COPD without AATD: a retrospective cohort study. Source: Virtual Congress 2021 – Biomarkers to phenotype COPD: prediction of exacerbations Year: 2021 Functional alterations of small airways in patients with alpha-1 antitrypsin deficiency (AATD) in a longitudinal study Source: Eur Respir J 2005; 26: Suppl. 49, 361s Year: 2005 Plasma levels of soluble CD14 in asymptomatic PiZZ and PiSZ subjects. Follow-up of the Swedish neonatal screening cohort Source: Annual Congress 2007 - Unravelling molecular mysteries of COPD Year: 2007 Early signs of COPD in 42 years old individuals with severe alpha-1-antitrypsin deficiency Source: Virtual Congress 2020 – COPD and the impact of comorbidities Year: 2020 Alpha-1 antitrypsin deficiency in patients with COPD/emphysema, bronchiectasis and asthma Source: Virtual Congress 2020 – New biomarkers for management of obstructive diseases Year: 2020 Risk of cancer in individuals with severe alpha-1-antitrypsin deficiency (PiZZ) compared with the Swedish general population Source: Virtual Congress 2020 – Asthma and COPD: How genetic and environment influences its developement? Year: 2020 Alpha 1-Antitrypsin deficiency (AATD) in patients with ARDS consequent to SARS-CoV-2 infection. Source: Virtual Congress 2021 – COVID – 19: treatments and predictive factors Year: 2021 Remission of adult-onset asthma is rare: a 15-year follow-up study Source: ERJ Open Res, 6 (4) 00620-2020; 10.1183/23120541.00620-2020 Year: 2020 Severity of lung disease in siblings with α-1-antitrypsin deficiency (AATD) Source: Annual Congress 2008 - COPD Year: 2008 Incidence of alpha-1-antitrypsin (α1-AT) deficiency in patients with COPD in Poland, preliminary report Source: Eur Respir J 2005; 26: Suppl. 49, 440s Year: 2005 Characteristics of COPD patients and alpha-1 antitrypsin deficiency at outpatient respiratory clinics. The EPOCONSUL study. Source: International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond Year: 2018 The national alpha-1 antitrypsin deficiency registry in Poland Source: International Congress 2015 – Chronic airway disorders: miscellaneous aspects Year: 2015 Prevalence of alpha-1 antitrypsin deficiency (AATD) and frequencies of alleles PI*S and PI*Z in patients with COPD in Brazil Source: Annual Congress 2013 –Assessing the prevalence of COPD in the general population Year: 2013 Aα360: A measure of disease and treatment efficacy in alpha-1-antitrypsin (A1AT) deficiency Source: Annual Congress 2010 - COPD: phenotyping and monitoring Year: 2010